4//SEC Filing
Karkus Ted William 4
Accession 0001493152-23-001631
CIK 0000868278other
Filed
Jan 16, 7:00 PM ET
Accepted
Jan 17, 4:37 PM ET
Size
9.8 KB
Accession
0001493152-23-001631
Insider Transaction Report
Form 4
Karkus Ted William
10% Owner
Transactions
- Exercise/Conversion
Option (right to buy)
2023-01-13−600,000→ 500,000 totalExercise: $0.60Exp: 2023-02-22→ Common Stock (600,000 underlying) - Exercise/Conversion
Common Stock, par value $0.005
2023-01-13$0.60/sh+600,000$360,000→ 3,671,318 total - Tax Payment
Common Stock, par value $0.005
2023-01-13$9.36/sh−319,231$2,988,002→ 3,352,087 total
Holdings
- 100,000(indirect: By Son)
Common Stock, par value $0.005
Footnotes (2)
- [F1]On January 13, 2023, the Reporting Person acquired net 280,769 shares of common stock upon the exercise of stock options to purchase 600,000 shares of common stock, less 319,231 shares of common stock withheld to cover the exercise price and applicable taxes.
- [F2]The option vested in 35 equal monthly installments of 63,888 shares on the 1st day of each month beginning on March 1, 2018 (the "Initial Vesting Date"), and one monthly installment of 63,920 shares on the 1st day of the 36th month following the Initial Vesting Date, as described in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of February 19, 2018.
Documents
Issuer
ProPhase Labs, Inc.
CIK 0000868278
Entity typeother
Related Parties
1- filerCIK 0001457896
Filing Metadata
- Form type
- 4
- Filed
- Jan 16, 7:00 PM ET
- Accepted
- Jan 17, 4:37 PM ET
- Size
- 9.8 KB